Etcembly

Exogene

This biotechnology company develops artificial intelligence and screening platforms to discover T-cell receptor-based cell therapies for oncology researchers and pharmaceutical developers.

Tessel Biosciences

The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Tolemy Bio

This company develops an AI platform to model and optimise cellular behaviour for biotechnology and pharmaceutical organisations developing advanced therapies.

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

Cime Therapeutics

The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.

Synteny Biotechnology

The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.

PharmEnable

This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.